Levitee Labs Inc. (LVT.CN) Research

Headquartered in Vancouver, Canada, Levitee Labs Inc., established in 2019, functions as a comprehensive wellness enterprise. The company is dedicated to delivering evidence-backed alternative medical treatments and pioneering psychedelic therapies, operating through its Medical Services and Selling Products divisions. Within its medical operations, Levitee Labs provides care and prescriptions for a range of conditions, including substance use disorders, various chronic pain conditions such as myofascial pain, fibromyalgia, neuropathy, and chronic regional pain syndrome, in addition to Hepatitis-C and diverse mental health issues. This segment encompasses the management of five Levitee Clinics and three Levitee Pharmacies situated in Alberta. Furthermore, the company facilitates electronic prescriptions for addiction treatment via its BlockMD platform and distributes a selection of wholesale supplements and superfoods under the Earth Circle Organics brand. The organization adopted its current name, Levitee Labs Inc., on November 30, 2020, having previously been known as Fibonacci Capital Corp.

Market snapshot

Symbol
LVT.CN
Price
$0.01
Day change
0.00%
Market cap
$502.1K
P/E ratio
-0.03x
52-week range
0.0-0.005
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Agra Ventures Ltd. (AGRA.CN)
  • Asia Green Biotechnology Corp. (ASIA.CN)
  • Biome Grow Inc. (BIO.CN)
  • Camarico Investment Group Ltd. (CIG.CN)
  • Global Hemp Group Inc. (GHG.CN)
  • Lords & Company Worldwide Holdings Inc. (LRDS.CN)
  • Medcolcanna Organics Inc. (MCCN.CN)
  • Molecule Holdings Inc. (MLCL.CN)

Open Levitee Labs Inc. (LVT.CN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.